@article{koyama_serum_2017,
	title = {Serum ferritin level is a prognostic marker in patients with peripheral {T}-cell lymphoma},
	volume = {39},
	issn = {1751-553X},
	doi = {10.1111/ijlh.12592},
	abstract = {INTRODUCTION

The prognostic value of serum ferritin level in patients with peripheral T-cell lymphoma (PTCL) remains unknown.


METHODS

We retrospectively analyzed clinical data from 78 consecutive patients with newly diagnosed PTCL that were treated with anthracycline-containing regimens between 1998 and 2011.


RESULTS

The patients consisted of 50 males and 28 females with a median age of 64 years (range, 16-83 years). The subtypes of PTCL were 39 PTCL, not otherwise specified and 39 angioimmunoblastic T-cell lymphoma (AITL). The median observation period for the surviving patients was 50 months. The overall survival (OS) was poorer in patients with serum ferritin level above the upper normal limit (n = 28), compared with patients with serum ferritin level within normal range (n = 50; 4-year OS: 23\% vs. 72\%; P {\textless} 0.001). In the multivariate analysis, poor performance status (P = 0.006) and elevated serum ferritin level (P = 0.018) were independent risk factors for poor OS.


CONCLUSION

Serum ferritin level is a useful prognostic marker for PTCL.},
	number = {1},
	journal = {International journal of laboratory hematology},
	author = {Koyama, S and Fujisawa, S and Watanabe, R and Itabashi, M and Ishibashi, D and Ishii, Y and Hattori, Y and Nakajima, Y and Motohashi, K and Takasaki, H and Kawasaki, R and Hashimoto, C and Yamazaki, E and Koharazawa, H and Takemura, S and Tomita, N and Sakai, R and Motomura, S and Nakajima, H},
	month = feb,
	year = {2017},
	pmid = {27885817},
	keywords = {Adolescent, Adult, Aged, Aged, 80 and over, Anthracyclines, Disease-Free Survival, Female, Ferritins, Humans, Lymphoma, T-Cell, Peripheral, Male, Middle Aged, Retrospective Studies, Survival Rate},
	pages = {112--117}
}

{"_id":"2bdFPjrP9fDSHWQYs","bibbaseid":"koyama-fujisawa-watanabe-itabashi-ishibashi-ishii-hattori-nakajima-etal-serumferritinlevelisaprognosticmarkerinpatientswithperipheraltcelllymphoma-2017","authorIDs":[],"author_short":["Koyama, S","Fujisawa, S","Watanabe, R","Itabashi, M","Ishibashi, D","Ishii, Y","Hattori, Y","Nakajima, Y","Motohashi, K","Takasaki, H","Kawasaki, R","Hashimoto, C","Yamazaki, E","Koharazawa, H","Takemura, S","Tomita, N","Sakai, R","Motomura, S","Nakajima, H"],"bibdata":{"bibtype":"article","type":"article","title":"Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma","volume":"39","issn":"1751-553X","doi":"10.1111/ijlh.12592","abstract":"INTRODUCTION The prognostic value of serum ferritin level in patients with peripheral T-cell lymphoma (PTCL) remains unknown. METHODS We retrospectively analyzed clinical data from 78 consecutive patients with newly diagnosed PTCL that were treated with anthracycline-containing regimens between 1998 and 2011. RESULTS The patients consisted of 50 males and 28 females with a median age of 64 years (range, 16-83 years). The subtypes of PTCL were 39 PTCL, not otherwise specified and 39 angioimmunoblastic T-cell lymphoma (AITL). The median observation period for the surviving patients was 50 months. The overall survival (OS) was poorer in patients with serum ferritin level above the upper normal limit (n = 28), compared with patients with serum ferritin level within normal range (n = 50; 4-year OS: 23% vs. 72%; P \\textless 0.001). In the multivariate analysis, poor performance status (P = 0.006) and elevated serum ferritin level (P = 0.018) were independent risk factors for poor OS. CONCLUSION Serum ferritin level is a useful prognostic marker for PTCL.","number":"1","journal":"International journal of laboratory hematology","author":[{"propositions":[],"lastnames":["Koyama"],"firstnames":["S"],"suffixes":[]},{"propositions":[],"lastnames":["Fujisawa"],"firstnames":["S"],"suffixes":[]},{"propositions":[],"lastnames":["Watanabe"],"firstnames":["R"],"suffixes":[]},{"propositions":[],"lastnames":["Itabashi"],"firstnames":["M"],"suffixes":[]},{"propositions":[],"lastnames":["Ishibashi"],"firstnames":["D"],"suffixes":[]},{"propositions":[],"lastnames":["Ishii"],"firstnames":["Y"],"suffixes":[]},{"propositions":[],"lastnames":["Hattori"],"firstnames":["Y"],"suffixes":[]},{"propositions":[],"lastnames":["Nakajima"],"firstnames":["Y"],"suffixes":[]},{"propositions":[],"lastnames":["Motohashi"],"firstnames":["K"],"suffixes":[]},{"propositions":[],"lastnames":["Takasaki"],"firstnames":["H"],"suffixes":[]},{"propositions":[],"lastnames":["Kawasaki"],"firstnames":["R"],"suffixes":[]},{"propositions":[],"lastnames":["Hashimoto"],"firstnames":["C"],"suffixes":[]},{"propositions":[],"lastnames":["Yamazaki"],"firstnames":["E"],"suffixes":[]},{"propositions":[],"lastnames":["Koharazawa"],"firstnames":["H"],"suffixes":[]},{"propositions":[],"lastnames":["Takemura"],"firstnames":["S"],"suffixes":[]},{"propositions":[],"lastnames":["Tomita"],"firstnames":["N"],"suffixes":[]},{"propositions":[],"lastnames":["Sakai"],"firstnames":["R"],"suffixes":[]},{"propositions":[],"lastnames":["Motomura"],"firstnames":["S"],"suffixes":[]},{"propositions":[],"lastnames":["Nakajima"],"firstnames":["H"],"suffixes":[]}],"month":"February","year":"2017","pmid":"27885817","keywords":"Adolescent, Adult, Aged, Aged, 80 and over, Anthracyclines, Disease-Free Survival, Female, Ferritins, Humans, Lymphoma, T-Cell, Peripheral, Male, Middle Aged, Retrospective Studies, Survival Rate","pages":"112–117","bibtex":"@article{koyama_serum_2017,\n\ttitle = {Serum ferritin level is a prognostic marker in patients with peripheral {T}-cell lymphoma},\n\tvolume = {39},\n\tissn = {1751-553X},\n\tdoi = {10.1111/ijlh.12592},\n\tabstract = {INTRODUCTION\n\nThe prognostic value of serum ferritin level in patients with peripheral T-cell lymphoma (PTCL) remains unknown.\n\n\nMETHODS\n\nWe retrospectively analyzed clinical data from 78 consecutive patients with newly diagnosed PTCL that were treated with anthracycline-containing regimens between 1998 and 2011.\n\n\nRESULTS\n\nThe patients consisted of 50 males and 28 females with a median age of 64 years (range, 16-83 years). The subtypes of PTCL were 39 PTCL, not otherwise specified and 39 angioimmunoblastic T-cell lymphoma (AITL). The median observation period for the surviving patients was 50 months. The overall survival (OS) was poorer in patients with serum ferritin level above the upper normal limit (n = 28), compared with patients with serum ferritin level within normal range (n = 50; 4-year OS: 23\\% vs. 72\\%; P {\\textless} 0.001). In the multivariate analysis, poor performance status (P = 0.006) and elevated serum ferritin level (P = 0.018) were independent risk factors for poor OS.\n\n\nCONCLUSION\n\nSerum ferritin level is a useful prognostic marker for PTCL.},\n\tnumber = {1},\n\tjournal = {International journal of laboratory hematology},\n\tauthor = {Koyama, S and Fujisawa, S and Watanabe, R and Itabashi, M and Ishibashi, D and Ishii, Y and Hattori, Y and Nakajima, Y and Motohashi, K and Takasaki, H and Kawasaki, R and Hashimoto, C and Yamazaki, E and Koharazawa, H and Takemura, S and Tomita, N and Sakai, R and Motomura, S and Nakajima, H},\n\tmonth = feb,\n\tyear = {2017},\n\tpmid = {27885817},\n\tkeywords = {Adolescent, Adult, Aged, Aged, 80 and over, Anthracyclines, Disease-Free Survival, Female, Ferritins, Humans, Lymphoma, T-Cell, Peripheral, Male, Middle Aged, Retrospective Studies, Survival Rate},\n\tpages = {112--117}\n}","author_short":["Koyama, S","Fujisawa, S","Watanabe, R","Itabashi, M","Ishibashi, D","Ishii, Y","Hattori, Y","Nakajima, Y","Motohashi, K","Takasaki, H","Kawasaki, R","Hashimoto, C","Yamazaki, E","Koharazawa, H","Takemura, S","Tomita, N","Sakai, R","Motomura, S","Nakajima, H"],"key":"koyama_serum_2017","id":"koyama_serum_2017","bibbaseid":"koyama-fujisawa-watanabe-itabashi-ishibashi-ishii-hattori-nakajima-etal-serumferritinlevelisaprognosticmarkerinpatientswithperipheraltcelllymphoma-2017","role":"author","urls":{},"keyword":["Adolescent","Adult","Aged","Aged","80 and over","Anthracyclines","Disease-Free Survival","Female","Ferritins","Humans","Lymphoma","T-Cell","Peripheral","Male","Middle Aged","Retrospective Studies","Survival Rate"],"downloads":0},"bibtype":"article","biburl":"https://api.zotero.org/users/585595/collections/74C3SXBK/items?key=1nXMl6HeUfXzWafuqAa4Ryj2&format=bibtex&limit=100\"></iframe","creationDate":"2019-05-09T15:52:34.304Z","downloads":0,"keywords":["adolescent","adult","aged","aged","80 and over","anthracyclines","disease-free survival","female","ferritins","humans","lymphoma","t-cell","peripheral","male","middle aged","retrospective studies","survival rate"],"search_terms":["serum","ferritin","level","prognostic","marker","patients","peripheral","cell","lymphoma","koyama","fujisawa","watanabe","itabashi","ishibashi","ishii","hattori","nakajima","motohashi","takasaki","kawasaki","hashimoto","yamazaki","koharazawa","takemura","tomita","sakai","motomura","nakajima"],"title":"Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma","year":2017,"dataSources":["Eax3HqcG6fcDtsCq9"]}